HealthTech & MedTech Thought Leadership
Nelson Advisors' thought leadership, published on www.healthcare.digital, receives widespread recognition through citations, media interviews and invitations to lead industry events, solidifying their position as specialised experts in European HealthTech and MedTech M&A.
Recent examples of this recognition include:
1. Citation by Major Consulting and Media Firms
Deloitte Feature: Nelson Advisors' research and insights have been featured in Deloitte's Life sciences and health care M&A update, citing their perspective on key trends like larger companies strategically acquiring innovative startups.
Mergermarket Interviews: Their partners are interviewed and quoted by Mergermarket, a leading intelligence service for M&A professionals, to provide expert commentary on topics such as "AI fuels European MedTech M&A despite regulatory uncertainty."
Tony Blair Institute for Global Change (TBI): The blog's analysis has been featured in a TBI publication on digital health, highlighting the impact of patient portals and digital transformation.
2. Leadership at Industry Events
The expertise of the Nelson Advisors team, often drawing directly from their published content, results in invitations to take leadership roles at major sector gatherings:
Panel Leadership: They are invited to lead the HealthTech M&A Panel and stream at the Healthcare Summit, an event attended by over a thousand operators, investors, and advisors in the health and social care sector.
Judging and Speaking Roles: Their partners are invited to judge prestigious industry awards (e.g., the Digital Health Hub Foundation Awards at HLTH 2025) and speak at high-profile events (e.g., Global Health Exhibition Investor Forum).
Academic Partnerships: They are noted for regularly guest lecturing and mentoring at leading institutions like the UCL Global Business School for Health and Oxford University, further extending their thought leadership's reach into academic and future business circles.
The content is valued in the industry for providing deeply specialised, actionable insights into market dynamics, M&A valuations, investor sentiment, and regulatory complexities (like the impact of the shift to value-based care and the AI revolution) within the niche HealthTech and MedTech sectors.